C6ORF153 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.789200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.844400E-02
Normal-vs-Stage2
8.142800E-01
Normal-vs-Stage3
9.944000E-01
Normal-vs-Stage4
9.779600E-02
Stage1-vs-Stage2
4.459100E-03
Stage1-vs-Stage3
6.931600E-01
Stage1-vs-Stage4
3.817900E-03
Stage2-vs-Stage3
8.000200E-01
Stage2-vs-Stage4
3.316000E-01
Stage3-vs-Stage4
4.739000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.635200E-01
Normal-vs-AfricanAmerican
8.945400E-01
Normal-vs-Asian
9.736400E-01
Caucasian-vs-AfricanAmerican
7.637200E-01
Caucasian-vs-Asian
5.399600E-01
AfricanAmerican-vs-Asian
8.510800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.273400E-01
Normal-vs-Female
7.152000E-01
Male-vs-Female
6.099200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.411600E-01
Normal-vs-Age(41-60Yrs)
5.901600E-01
Normal-vs-Age(61-80Yrs)
8.947000E-01
Normal-vs-Age(81-100Yrs)
5.558600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.998200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.827600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.626800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.455570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.874800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.906000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.337800E-01
Normal-vs-Daily Drinker
6.767000E-01
Normal-vs-Weekly Drinker
7.952400E-02
Normal-vs-Occasional Drinker
6.810200E-02
Normal-vs-Social Drinker
8.004000E-01
Non Drinker-vs-Daily Drinker
4.879600E-01
Non Drinker-vs-Weekly Drinker
5.096500E-02
Non Drinker-vs-Occasional Drinker
4.464100E-02
Non Drinker-vs-Social Drinker
5.652200E-01
Daily Drinker-vs-Weekly Drinker
2.118200E-02
Daily Drinker-vs-Occasional Drinker
2.050200E-02
Daily Drinker-vs-Social Drinker
2.467000E-01
Weekly Drinker-vs-Occasional Drinker
9.635400E-01
Weekly Drinker-vs-Social Drinker
1.381980E-01
Occasional Drinker-vs-Social Drinker
1.228430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.600400E-01
Normal-vs-Grade 2
8.362800E-01
Normal-vs-Grade 3
8.255800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.952500E-02
Grade 1-vs-Grade 3
1.584250E-01
Grade 1-vs-Grade 4
7.600400E-01
Grade 2-vs-Grade 3
7.542800E-01
Grade 2-vs-Grade 4
8.362800E-01
Grade 3-vs-Grade 4
8.255800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.042200E-01
Normal-vs-NonDiabetic
6.755800E-01
Diabetic-vs-NonDiabetic
9.392000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.320400E-01
Normal-vs-NoPancreatitis
2.813200E-01
Pancreatitis-vs-NoPancreatitis
5.360400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.587800E-01
Normal-vs-N1
8.274200E-01
N0-vs-N1
4.183600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.531830E-02
Normal-vs-TP53-NonMutant
6.005200E-01
TP53-Mutant-vs-TP53-NonMutant
1.880210E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
